SOCS3_HUMAN - dbPTM
SOCS3_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID SOCS3_HUMAN
UniProt AC O14543
Protein Name Suppressor of cytokine signaling 3
Gene Name SOCS3
Organism Homo sapiens (Human).
Sequence Length 225
Subcellular Localization
Protein Description SOCS family proteins form part of a classical negative feedback system that regulates cytokine signal transduction. SOCS3 is involved in negative regulation of cytokines that signal through the JAK/STAT pathway. Inhibits cytokine signal transduction by binding to tyrosine kinase receptors including gp130, LIF, erythropoietin, insulin, IL12, GCSF and leptin receptors. Binding to JAK2 inhibits its kinase activity. Suppresses fetal liver erythropoiesis. Regulates onset and maintenance of allergic responses mediated by T-helper type 2 cells. Regulates IL-6 signaling in vivo (By similarity). Probable substrate recognition component of a SCF-like ECS (Elongin BC-CUL2/5-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. Seems to recognize IL6ST (By similarity)..
Protein Sequence MVTHSKFPAAGMSRPLDTSLRLKTFSSKSEYQLVVNAVRKLQESGFYWSAVTGGEANLLLSAEPAGTFLIRDSSDQRHFFTLSVKTQSGTKNLRIQCEGGSFSLQSDPRSTQPVPRFDCVLKLVHHYMPPPGAPSFPSPPTEPSSEVPEQPSAQPLPGSPPRRAYYIYSGGEKIPLVLSRPLSSNVATLQHLCRKTVNGHLDSYEKVTQLPGPIREFLDQYDAPL
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
6Ubiquitination--MVTHSKFPAAGMS
--CCCCCCCCCCCCC
48.0012459551
13O-linked_GlycosylationKFPAAGMSRPLDTSL
CCCCCCCCCCCCCCE
29.8130379171
23UbiquitinationLDTSLRLKTFSSKSE
CCCCEEEEECCCCCH
40.88-
28UbiquitinationRLKTFSSKSEYQLVV
EEEECCCCCHHHHHH
46.22-
86PhosphorylationFFTLSVKTQSGTKNL
EEEEEEEECCCCEEE
26.30-
101PhosphorylationRIQCEGGSFSLQSDP
EEEEECCCEEECCCC
23.6322210691
165PhosphorylationGSPPRRAYYIYSGGE
CCCCCEEEEEEECCE
6.65-
166PhosphorylationSPPRRAYYIYSGGEK
CCCCEEEEEEECCEE
7.75-
179PhosphorylationEKIPLVLSRPLSSNV
EEEEEEEECCCCCCH
25.1124719451
195UbiquitinationTLQHLCRKTVNGHLD
HHHHHHHHHHCCCCC
56.69-
204PhosphorylationVNGHLDSYEKVTQLP
HCCCCCHHHHHHCCC
21.3116352613
206UbiquitinationGHLDSYEKVTQLPGP
CCCCHHHHHHCCCCC
42.20-
221PhosphorylationIREFLDQYDAPL---
HHHHHHHCCCCC---
17.4616352613

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
204YPhosphorylationKinaseJAK2O60674
PSP
204YPhosphorylationKinaseLCKP06239
PSP
221YPhosphorylationKinaseJAK2O60674
PSP
221YPhosphorylationKinaseLCKP06239
PSP
-KUbiquitinationE3 ubiquitin ligaseSOCS2O14508
PMID:22199232

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of SOCS3_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of SOCS3_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PIN1_HUMANPIN1physical
16169070
PRLR_HUMANPRLRphysical
11713228
CXCR4_HUMANCXCR4physical
12163560
LEPR_HUMANLEPRphysical
11018044
JAK2_HUMANJAK2physical
10882725
EPOR_HUMANEPORphysical
10882725
JAK2_HUMANJAK2physical
10421843
CSF1R_HUMANCSF1Rphysical
12133942
RASA1_HUMANRASA1physical
11331873
JAK2_HUMANJAK2physical
9344848
FAK2_HUMANPTK2Bphysical
9344848
IGF1R_HUMANIGF1Rphysical
11071852
NONO_HUMANNONOphysical
18952062
M3K7_HUMANMAP3K7physical
16543409
TRAF6_HUMANTRAF6physical
16543409
ACADV_HUMANACADVLphysical
22093833
FAK1_HUMANPTK2physical
18031698
VHL_HUMANVHLphysical
21685897
DAB1_HUMANDAB1physical
17974915
CUL5_HUMANCUL5physical
17135358
ELOB_HUMANTCEB2physical
17135358
ELOC_HUMANTCEB1physical
17135358
ETV6_HUMANETV6physical
11314018
JAK2_HUMANJAK2physical
11314018
JAK2_HUMANJAK2physical
19543316
JIP1_HUMANMAPK8IP1physical
18055217
CUED2_HUMANCUEDC2physical
22084247
MAP1S_HUMANMAP1Sphysical
19027008
SOCS2_HUMANSOCS2physical
16199887
FAK2_HUMANPTK2Bphysical
18507841
SIGL7_HUMANSIGLEC7physical
17138568
PTN11_HUMANPTPN11physical
17138568
ELOC_HUMANTCEB1physical
12783885
FGFR3_HUMANFGFR3physical
16410555
NFKB1_HUMANNFKB1physical
21451109
TF65_HUMANRELAphysical
21451109
REL_HUMANRELphysical
21451109
IKBA_HUMANNFKBIAphysical
21451109
TNF10_HUMANTNFSF10physical
21308719
JAK2_HUMANJAK2physical
22342841
JAK1_HUMANJAK1physical
10373548
IL2RB_HUMANIL2RBphysical
10373548
JAK2_HUMANJAK2physical
15514089
IRS1_HUMANIRS1physical
15514089
IRS2_HUMANIRS2physical
15514089
INSR_HUMANINSRphysical
15514089
ELOB_HUMANTCEB2physical
16007195
TFDP1_HUMANTFDP1physical
18687693
A4_HUMANAPPphysical
21832049
CUL5_HUMANCUL5physical
15601820
RBX2_HUMANRNF7physical
15601820
ELOB_HUMANTCEB2physical
15601820
ELOC_HUMANTCEB1physical
15601820
CUL5_MOUSECul5physical
15601820
RBX2_MOUSERnf7physical
15601820
ELOB_MOUSETceb2physical
15601820
ELOC_MOUSETceb1physical
15601820
ABL1_HUMANABL1physical
22787435
TFR2_HUMANTFR2physical
21988832
TES_HUMANTESphysical
21988832
TXD11_HUMANTXNDC11physical
21988832
K1958_HUMANKIAA1958physical
25416956
PTK6_HUMANPTK6physical
22547065
TBK1_HUMANTBK1physical
25939384
SH22A_HUMANSH2D2Aphysical
25814554
TRDN_HUMANTRDNphysical
25814554
1433T_HUMANYWHAQphysical
25814554
JAK2_HUMANJAK2physical
24438103
IL6RB_HUMANIL6STphysical
24438103
AMRA1_HUMANAMBRA1physical
28514442
RGP1_HUMANRGP1physical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of SOCS3_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP